Home News Company news...
April 25, 2024

MEBO International Chairman Kevin Xu Appointed to San Francisco Zoo Board

On April 20, 2024, Kevin Xu, Chairman of MEBO International, was appointed to the San Francisco Zoo's Board of Directors. This significant appointment came during Xu's visit to the zoo, where he met with Zoo Director Tanya Peterson.


The San Francisco Zoo is set to welcome its first pair of giant pandas in decades, thanks to a signed agreement between the China Wildlife Conservation Association and the zoo. This landmark event, scheduled for 2025, symbolizes a deepening of China-U.S. friendship and cooperation.


Located on the Pacific coast, the San Francisco Zoo is home to over 1,000 animals across 250 species. The zoo serves as an urban oasis, showcasing a mix of native and exotic plants alongside rare and rescued animals.



About MEBO

Founded in 1987 by Professor Rongxiang Xu, a distinguished Chinese life scientist, Mebo Group is a multinational headquartered in both China and the USA. It integrates research, development, and sales across the pharmaceuticals, medical devices, health foods, and cosmetics sectors.

At its core, Mebo focuses on regenerative life sciences, innovating with over 100 patents and more than ten joint research bases to enhance and enable the body's own regenerative abilities.

As a leader in regenerative life science, Mebo's extensive research facilities and products impact over 100 countries globally, pioneering new frontiers in the regenerative life world.


About Kevin Xu

Kevin Xu serves as the CEO of MEBO Group and Skingenix Inc., bringing pioneering advancements in the health and skincare industries. He holds prestigious roles including the Co-Chair of the APEC 2023 Host Committee. Additionally, he is an Executive Board member and Co-Chair of the International Committee at the Bay Area Council, actively shaping international policies and collaborations.

Xu's commitment extends beyond corporate leadership to significant philanthropic and advisory roles. He founds the National Rongxiang Xu Foundation, the Human Heritage Project, and leads initiatives like the California Fight Against Coronavirus. His influence spans academia and policy-making, serving on advisory boards at top institutions like Harvard Medical School and Caltech, and initiatives such as the Kevin Xu Neurotechnology Center.

Recognized globally, Xu contributes to high-profile publications and has been honored at the United Nations and by the White House. His leadership fosters broad societal impact, driving forward both medical innovation and global health initiatives.